Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

Index by author

September-October 2023; Volume 37,Issue 5
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Abdelrahman, AMRO M.

    1. Open Access
      Therapeutic Efficacy of Temsirolimus in a Patient-derived Model of Metastatic Fibrolamellar Hepatocellular Carcinoma
      JENNIFER L. LEITING, MATTHEW C. HERNANDEZ, JOHN R. BERGQUIST, JENNIFER A. YONKUS, AMRO M. ABDELRAHMAN, MICHAEL S. TORBENSON, NGUYEN H. TRAN, THORVARDUR R. HALFDANARSON, RONDELL P. GRAHAM, RORY L. SMOOT and MARK J. TRUTY
      In Vivo September 2023, 37 (5) 1940-1950; DOI: https://doi.org/10.21873/invivo.13290
  2. Ahn, EUN-JUNG

    1. Open Access
      Orthotopic Mouse Models of Urinary Bladder Cancer
      JI-IN NOH, EUN-JUNG AHN, MYUNG-GIUN NOH, KYUNG-SUB MOON, EUIHEON CHUNG, CHAN CHOI, KYUNG-HWA LEE and SUNG SUN KIM
      In Vivo September 2023, 37 (5) 2039-2043; DOI: https://doi.org/10.21873/invivo.13301
  3. Akahane, KEIKO

    1. Open Access
      Clinical Outcomes of Radiotherapy for Stage 1 Glottic Carcinoma: Comparing Accelerated Hyperfractionation and Once-daily Fractionation
      MASASHI ENDO, YUKIKO FUKUDA, KOHEI OKADA, KAZUNARI OGAWA, MICHIKO NAKAMURA, SATORU TAKAHASHI, ERI MURAKAMI, CHIAKI SHIBAYAMA, MASAHIRO KAWAHARA, KEIKO AKAHANE, RYUTARO ONAGA, TAKAFUMI NAGATOMO, TAKEHARU KANAZAWA, HIROSHI NISHINO, HARUSHI MORI and KATSUYUKI SHIRAI
      In Vivo September 2023, 37 (5) 2320-2326; DOI: https://doi.org/10.21873/invivo.13335
  4. Akioka, KOHEI

    1. Open Access
      Acupuncture Treatment Improves Transport Stress in Microminipigs Through the Acupoint in Ears
      MOE IJIRI, KOHEI AKIOKA, TAISUKE KITANO, HIROSHI MIURA, HISAYA K. ONO, RYOTA TERASHIMA, YOSHIKAZU FUJIMOTO, TOMOHIDE MATSUO, OSAMU YAMATO and HIROAKI KAWAGUCHI
      In Vivo September 2023, 37 (5) 2100-2104; DOI: https://doi.org/10.21873/invivo.13307
  5. Amendt, KLAUS

    1. Open Access
      Comparison of Functional and Morphological Estimates of Vascular Age
      MARTIN SIGL, LAURA WINTER, GERHARD SCHUMACHER, STEFANIE CHRISTINA HELMKE, TETYANA SHCHETYNSKA-MARINOVA, KLAUS AMENDT, DANIEL DUERSCHMIED and ANNA LENA HOHNECK
      In Vivo September 2023, 37 (5) 2178-2187; DOI: https://doi.org/10.21873/invivo.13317
  6. Amoroso, DOMENICO

    1. Open Access
      Baseline Troponin Level and Cardiac Toxicity in HER2-positive Early Breast Cancer Patients Receiving Trastuzumab
      MARIA LAURA CANALE, GIANCARLO CASOLO, SARA DONATI, IRMA BISCEGLIA, CHETI PUCCETTI, DOMENICO AMOROSO, ELIO VENTURINI, NICOLA MAUREA, FABIO MARIA TURAZZA and ANDREA CAMERINI
      In Vivo September 2023, 37 (5) 2139-2146; DOI: https://doi.org/10.21873/invivo.13311
  7. Andrzejewski, WALDEMAR

    1. Open Access
      Effects of the Foam Massage Roller on VEGF-A and FGF-2 Blood Levels in Young Men
      ADAM ROSLANOWSKI, ALEKSANDRA PARTYNSKA, KATARZYNA RATAJCZAK-WIELGOMAS, ALICJA KMIECIK, JEDRZEJ GRZEGRZOLKA, PIOTR DZIEGIEL, ADAM JANUSZKO, DARIUSZ LENART and WALDEMAR ANDRZEJEWSKI
      In Vivo September 2023, 37 (5) 2057-2069; DOI: https://doi.org/10.21873/invivo.13303
  8. Anggraeni, INDIANA GITA

    1. Open Access
      Renieramycin T Derivative DH_22 Induces p53-dependent Apoptosis in Lung Cancer Cells
      INDIANA GITA ANGGRAENI, ZIN ZIN EI, DAIKI HOTTA, MASASHI YOKOYA and PITHI CHANVORACHOTE
      In Vivo September 2023, 37 (5) 1960-1966; DOI: https://doi.org/10.21873/invivo.13292
  9. Aoyama, TORU

    1. Open Access
      Influence of the Oral Health Assessment Tool Score on Survival of Patients With Esophageal Cancer
      HIROSHI TAMAGAWA, AYAKO TAMAGAWA, TORU AOYAMA, ITARU HASHIMOTO, YUKIO MAEZAWA, KENTARO HARA, AYA KATO, NATSUMI KAMIYA, KAZUKI OTANI, MASAKATSU NUMATA, KEISUKE KAZAMA, JYUNYA MORITA, MIE TANABE, SHIZUNE ONUMA, HARUHIKO CHO, SHO SAWAZAKI, TAKASHI OHSHIMA, NORIO YUKAWA, KENJI MITSUDO, AYA SAITO and YASUSHI RINO
      In Vivo September 2023, 37 (5) 2253-2259; DOI: https://doi.org/10.21873/invivo.13327
  10. Arima, TAKUJI

    1. Open Access
      Intensity-dependent Temperature Rise Induced by Local Exposure to 26.5 GHz Quasi-Millimeter-Wave in Rat
      ETSUKO IJIMA, KUN LI, TAKASHI HIKAGE, AKIKO NAGAI, YASUTAKA MURAKAMI, TAKUJI ARIMA, TATSUYA ISHITAKE and HIROSHI MASUDA
      In Vivo September 2023, 37 (5) 2092-2099; DOI: https://doi.org/10.21873/invivo.13306
« Previous (Pages : 1 2 3 4 5 6 ... 46) Next »
Back to top
PreviousNext

In this issue

In Vivo: 37 (5)
In Vivo
Vol. 37, Issue 5
September-October 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)

Issue highlights

  • Therapeutic Efficacy of Temsirolimus in a Patient-derived Model of Metastatic Fibrolamellar Hepatocellular Carcinoma
  • Rapid Reduction of CEA and Stable Metastasis in an NRAS-mutant Rectal-Cancer Patient Treated With FOLFIRI and Bevacizumab Combined With Oral Recombinant Methioninase and a Low-Methionine Diet Upon Metastatic Recurrence After FOLFIRI and Bevacizumab Treatment Alone
  • Renieramycin T Derivative DH_22 Induces p53-dependent Apoptosis in Lung Cancer Cells
  • In Vitro Carbon Ion Beam and Gemcitabine Chemoradiation in a Mucoepidermoid Carcinoma Cell Line
  • Determination of the Possible Target Genes of Hepatoma-derived Growth Factor in Hepatoma Cells
Sign up for alerts
  • Top Topics
  • Most Cited
  • Most Read
Loading
In Vivo

© 2026 In Vivo

Powered by HighWire